The mechanism of tumor induction by unsymmetric nitrosamines is poorly understood. Alpha-hydroxylation activates these carcinogens to DNA alkylating agents by generating a metabolite that decomposes to an aldehyde and a diazohydroxide. The diazohydroxide, presumably via a diazonium ion, alkylates DNA. Unsymmetric nitrosamines have two activation pathways that lead to two different types of DNA adducts. Interactions between these two pathways likely contribute to the carcinogenic activity of the nitrosamine. In addition, the aldehyde metabolites are themselves chemically reactive and may contribute to the toxicological properties of nitrosamines. Interactions between the various reactive nitrosamine metabolites will be explored with 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK). This tobacco-specific nitrosamine selectively induces lung tumors in laboratory animals and is a possible human carcinogen. NNK is activated to either a methylating agent or a pyridyloxobutylating agent. Experimental data support a carcinogenic mechanism for this compound in which the formation and persistence of O6-methylguanine (O6-mG) is important for the initiation of tumorigenesis by NNK. Pyridyloxobutylating agents and NNK-derived aldehydes, formaldehyde and 4-oxo-1-(3-pyridyl)-1-butanone, are capable of interfering the repair of O6-mG by O6-alkylguanine-DNA alkyltransferase (AGT). In vivo levels of the AGT substrate pyridyloxobutyl DNA adduct, O6-[4-oxo-4-(3-pyridyl)butyl] - guanine, are insufficient to explain the extent of O6-mG persistence in NNK-treated mice. Therefore, there appears to be other mechanisms by which nitrosamine metabolites interfere with O6-mG repair. The objective of this application is to explore the mechanisms by which nitrosamine metabolites can reduce the repair of O6-mG by AGT. The central hypothesis is that nitrosamine metabolites can inactivate DNA repair pathways, leading to increased persistence of promutagenic adducts. These mechanisms differ from a mechanism involving competition between O6-alkylguanine adducts for repair by AGT. We plan to test our central hypothesis by pursuing the following specific aims: 1) Determine the importance of direct alkylation of AGT by diazohydroxides on AGT depletion; 2) Determine the contribution of aldehydes to the depletion of AGT following nitrosamine exposure; 3) Determine the effect of nitrosamine metabolites on the degradation rate of inactivated AGT; 4) Determine the ability of nitrosamine metabolites to influence the rate of AGT protein synthesis. The results of our studies will lead to a better understanding of mechanisms of lung cancer induction. In addition, this mechanism is likely applicable to other unsymmetric nitrosamines as well as carcinogenic mixtures such as tobacco smoke, a known human carcinogen.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA059887-12
Application #
6858644
Study Section
Special Emphasis Panel (ZRG1-PTHB (04))
Program Officer
Poland, Alan P
Project Start
1993-05-05
Project End
2007-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
12
Fiscal Year
2005
Total Cost
$254,002
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Peterson, Lisa A (2017) Context Matters: Contribution of Specific DNA Adducts to the Genotoxic Properties of the Tobacco-Specific Nitrosamine NNK. Chem Res Toxicol 30:420-433
Peterson, Lisa A; Urban, Anna M; Vu, Choua C et al. (2013) Role of aldehydes in the toxic and mutagenic effects of nitrosamines. Chem Res Toxicol 26:1464-73
Tubbs, Julie L; Latypov, Vitaly; Kanugula, Sreenivas et al. (2009) Flipping of alkylated DNA damage bridges base and nucleotide excision repair. Nature 459:808-13
Peterson, Lisa A; Wagener, Tanja; Sies, Helmut et al. (2007) Decomposition of S-nitrosocysteine via S- to N-transnitrosation. Chem Res Toxicol 20:721-3
Coulter, Richard; Blandino, Maureen; Tomlinson, Jessica M et al. (2007) Differences in the rate of repair of O6-alkylguanines in different sequence contexts by O6-alkylguanine-DNA alkyltransferase. Chem Res Toxicol 20:1966-71
Mijal, Renee S; Kanugula, Sreenivas; Vu, Choua C et al. (2006) DNA sequence context affects repair of the tobacco-specific adduct O(6)-[4-Oxo-4-(3-pyridyl)butyl]guanine by human O(6)-alkylguanine-DNA alkyltransferases. Cancer Res 66:4968-74
Choi, Jeong-Yun; Chowdhury, Goutam; Zang, Hong et al. (2006) Translesion synthesis across O6-alkylguanine DNA adducts by recombinant human DNA polymerases. J Biol Chem 281:38244-56
Mijal, Renee S; Loktionova, Natalia A; Vu, Choua C et al. (2005) O6-pyridyloxobutylguanine adducts contribute to the mutagenic properties of pyridyloxobutylating agents. Chem Res Toxicol 18:1619-25
Mijal, Renee S; Thomson, Nicole M; Fleischer, Nancy L et al. (2004) The repair of the tobacco specific nitrosamine derived adduct O6-[4-Oxo-4-(3-pyridyl)butyl]guanine by O6-alkylguanine-DNA alkyltransferase variants. Chem Res Toxicol 17:424-34
Thomson, Nicole M; Mijal, Renee S; Ziegel, Rebecca et al. (2004) Development of a quantitative liquid chromatography/electrospray mass spectrometric assay for a mutagenic tobacco specific nitrosamine-derived DNA adduct, O6-[4-Oxo-4-(3-pyridyl)butyl]-2'-deoxyguanosine. Chem Res Toxicol 17:1600-6

Showing the most recent 10 out of 22 publications